Evaluation of Prostate Cancer with PET/MRI.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 27694163.
- Also identified by PMC identifier 12530357.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In the ongoing effort to understand and cure prostate cancer, imaging modalities are constantly evolving to assist in clinical decisions. Multiparametric MRI can be used to direct prostate biopsies, improve diagnostic yield, and help clinicians make more accurate decisions. PET is superior in providing biologic information about the cancer and is sensitive and highly specific. Integrated PET/MRI is a welcome technical advance with great potential to influence the diagnosis and management of prostate cancer in clinical practice.
Medical subject headings
- Image Enhancement
- Magnetic Resonance Imaging
- Positron-Emission Tomography
- Prostatic Neoplasms